Susquehanna International Group’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Susquehanna International Group’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,900	Closed	-$242K	–	12998
2022 Q4	$242K	Buy	3,900 +300	+8%	+$18K	﹤0.01%	9639
2022 Q3	$203K	Buy	+3,600	New	+$222K	﹤0.01%	10800
2022 Q2	–	Sell	-3,600	Closed	-$233K	–	13357
2022 Q1	$233K	Buy	+3,600	New	+$228K	﹤0.01%	10871
2020 Q3	–	Sell	-10,200	Closed	-$523K	–	10809
2020 Q2	$523K	Sell	10,200 -7,500	-42%	-$377K	﹤0.01%	7272
2020 Q1	$794K	Buy	17,700 +8,700	+97%	+$439K	﹤0.01%	5909
2019 Q4	$480K	Buy	+9,000	New	+$444K	﹤0.01%	7064
2019 Q1	–	Sell	-17,400	Closed	-$816K	–	9307
2018 Q4	$816K	Sell	17,400 -3,300	-16%	-$169K	﹤0.01%	5072
2018 Q3	$1.16M	Sell	20,700 -2,700	-12%	-$148K	﹤0.01%	4937
2018 Q2	$1.18M	Buy	23,400 +11,100	+90%	+$550K	﹤0.01%	4998
2018 Q1	$605K	Buy	12,300 +7,500	+156%	+$385K	﹤0.01%	6246
2017 Q4	$247K	Buy	+4,800	New	+$247K	﹤0.01%	7902

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Susquehanna International Group's IHE Position: Q2 2026 in Review

Susquehanna International Group reduced its iShares US Pharmaceuticals ETF (IHE) stake by 28% in Q2 2026, selling an estimated $1.53M and leaving 43,401 shares worth $4.3M. The position accounts for ﹤0.01% of the portfolio, ranked #4925.

Susquehanna International Group first reported a position in IHE in Q2 2013 and has held it in 51 quarters since. The position peaked at $8.23M in Q2 2023. 210 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

Susquehanna International Group held 43,401 shares of iShares US Pharmaceuticals ETF worth $4.3M as of Q2 2026.
Susquehanna International Group sold 17,000 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $1.53M.
iShares US Pharmaceuticals ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #4925 holding.
Susquehanna International Group first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and has held it in 51 quarters since.
Susquehanna International Group's iShares US Pharmaceuticals ETF position peaked at $8.23M in Q2 2023.
210 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.